NNA: (1R,2S,5S)-3-[N-({1-[(tert-butylsulfonyl)methyl]cyclohexyl}carbamoyl)-3-methyl-L-valyl]-N-{(1S)-1-[(1R)-2-(cyclopropylamino)-1-hydroxy-2-oxoethyl]pentyl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide
NNA is a Ligand Of Interest in 3LON designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 3LON_NNA_A_999 | 35% | 31% | 0.209 | 0.898 | 1.31 | 1.45 | 5 | 8 | 4 | 0 | 100% | 1 |
| 7JYC_NNA_A_401 | 83% | 57% | 0.087 | 0.945 | 0.76 | 0.91 | 1 | 4 | 1 | 0 | 100% | 1 |
| 7D1O_NNA_A_401 | 71% | 70% | 0.114 | 0.933 | 0.54 | 0.62 | 1 | - | 3 | 0 | 100% | 1 |
| 6XQT_NNA_A_401 | 70% | 2% | 0.136 | 0.955 | 3.92 | 2.66 | 22 | 22 | 2 | 0 | 100% | 1 |
